Recent studies in photodynamic therapy for cancer treatment: From basic research to clinical trials
TE Kim, JE Chang - Pharmaceutics, 2023 - mdpi.com
Photodynamic therapy (PDT) is an emerging and less invasive treatment modality for
various types of cancer. This review provides an overview of recent trends in PDT research …
various types of cancer. This review provides an overview of recent trends in PDT research …
Novel systemic treatment modalities including immunotherapy and molecular targeted therapy for recurrent and metastatic head and neck squamous cell carcinoma
Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancers
worldwide. More than half of patients with HNSCC eventually experience disease …
worldwide. More than half of patients with HNSCC eventually experience disease …
Treg-dominant tumor microenvironment is responsible for hyperprogressive disease after PD-1 blockade therapy
H Wakiyama, T Kato, A Furusawa, R Okada… - Cancer Immunology …, 2022 - AACR
Abstract Programmed cell death 1 (PD-1) blockade therapy can result in dramatic responses
in some patients with cancer. However, about 15% of patients receiving PD-1 blockade …
in some patients with cancer. However, about 15% of patients receiving PD-1 blockade …
Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis
Fluorescence-guided intervention can bolster standard therapies by detecting and treating
microscopic tumors before lethal recurrence. Tremendous progress in photoimmunotherapy …
microscopic tumors before lethal recurrence. Tremendous progress in photoimmunotherapy …
Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma
NL Miyazaki, A Furusawa, PL Choyke, H Kobayashi - Cancers, 2023 - mdpi.com
Simple Summary RM-1929 near-infrared photoimmunotherapy (NIR-PIT) is an emerging
treatment that is currently being investigated under a world-wide Phase III clinical trial and …
treatment that is currently being investigated under a world-wide Phase III clinical trial and …
Near-infrared photoimmunotherapy for oropharyngeal cancer
D Nishikawa, H Suzuki, S Beppu, H Terada, M Sawabe… - Cancers, 2022 - mdpi.com
Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) represents a potential novel
treatment modality for a range of cancer types, including head and neck cancers. NIR-PIT is …
treatment modality for a range of cancer types, including head and neck cancers. NIR-PIT is …
[HTML][HTML] Research progress in inducing immunogenic cell death of tumor cells
D Xie, Q Wang, G Wu - Frontiers in Immunology, 2022 - frontiersin.org
Immunogenic cell death (ICD) is a regulated cell death (RCD) pathway. In response to
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …
physical and chemical signals, tumor cells activate specific signaling pathways that stimulate …
Quality-of-life evaluation of patients with unresectable locally advanced or locally recurrent head and neck carcinoma treated with head and neck …
I Okamoto, T Okada, K Tokashiki, K Tsukahara - Cancers, 2022 - mdpi.com
Simple Summary Head and neck photoimmunotherapy (HN-PIT) is a new treatment
developed for local control of head and neck carcinoma. This study assessed the quality of …
developed for local control of head and neck carcinoma. This study assessed the quality of …
The chemical basis of cytotoxicity of silicon-phthalocyanine-based near infrared photoimmunotherapy (NIR-PIT) and its implications for treatment monitoring
H Kobayashi, PL Choyke, M Ogawa - Current Opinion in Chemical Biology, 2023 - Elsevier
Near infrared photoimmunotherapy (NIR-PIT) is a new cancer therapy based on the photo-
induced ligand release reaction of a silicon–phthalocyanine derivative, IRDye700DX …
induced ligand release reaction of a silicon–phthalocyanine derivative, IRDye700DX …
Near-infrared photoimmunotherapy (NIR-PIT) in urologic cancers
Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-
targeted therapy that induces rapid cancer cell death by systemically administering an …
targeted therapy that induces rapid cancer cell death by systemically administering an …